1Y Close · As of Aug 26, 2026
IL DONG PHARMACEUTICAL operates in the Pharmaceuticals sector.
Legal name: IL DONG PHARMACEUTICAL CO., LTD.
In fiscal year 2025, IL DONG PHARMACEUTICAL (249420) reported revenue of 566.9 billion KRW, down 7.8% from 614.9 billion KRW a year earlier.
Operating profit was 19.5 billion KRW and net income was 23.7 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 475.8 billion KRW, with a P/B of 1.99.
These figures can be verified in the DART filing (receipt no. 20260318000787).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 566.9B | 19.5B | 23.7B |
| 2024 | 614.9B | 13.1B | -12.4B |
| 2023 | 600.8B | -53.9B | -81.0B |
Recent Filings
Semi-Annual Report (2026.06)
Consolidated Operating (Preliminary) Earnings (Fair Disclosure)
Fair Trade Compliance Status (Informational Disclosure)
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-07-30 | Consolidated Operating (Preliminary) Earnings (Fair Disclosure) |
| 2026-07-30 | Fair Trade Compliance Status (Informational Disclosure) |